



RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS 




M. SUDHAKAR, K. VIJAYASRI, SRIDHAR SIDDIRAJU1, MATURI NIRUPAMA2,
Department of Pharmaceutical Analysis and Quality Assurance
* 
2; Department of Pharmaceutical Chemistry1
Received: 16 Aug 2014 Revised and Accepted: 15 Sep 2014 
, Malla Reddy College of 
Pharmacy, Hyderabad, Telangana, India. 
Email: maturi.nirupama@gmail.com  
ABSTRACT 
Objective: The aim of this work was to develop and validate a simple Reverse Phase-High Performance Liquid Chromatography method for the 
simultaneous estimation of Clindamycin and Clotrimazole in pharmaceutical dosage forms. 
Methods: The mobile phase consists of phosphate buffer and Acetonitrile in the ratio of (48:52) with gradient programming, Hypersil BDS (250×4.6 
mm,5µ) column used as stationary phase with a flow rate of 1 ml/min, injection volume 10 µl and the run time was 10 min. Detection wavelength 
was at 220 nm by using Photo Diode Array detector.  
Results: The retention times of Clindamycin and Clotrimazole were found to be 2.2 min and 5.7 min respectively. The method was validated 
according to ICH guidelines. Validation parameters like accuracy, precision, linearity, range, limit of detection, limit of quantification and robustness 
all were within the limits. The linearity responses of Clindamycin and Clotrimazole were found to be in the concentration ranges of 25-150 µg/ml 
and 50-300 µg/ml. The percentage recovery for both drugs was found in the range of 99-100%. The LOD & LOQ values for were found to be 
1.29µg/ml and 3.93µg/ml and Clotrimazole were found to be 1.31µg/ml and 3.96 µg/ml, respectively. 
Conclusion: The results obtained are accurate and within the limits. Hence this method can be applicable for the estimation of Clindamycin and 
Clotrimazole in pharmaceutical dosage forms. 
Keywords: Clindamycin and Clotrimazole, RP-HPLC, Validation.  
 
INTRODUCTION 
Clindamycin is an antibacterial, broad-spectrum antibiotic derived from 
lincomycin. Clindamycin is used for the topical and systemic treatment. 
And it is effective as an anti-aerobic and anti-protozoal. May be useful in 
respiratory tract infections, and also to treat gynecological infection. 
Chemically Clindamycin is methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-
trans-4-propyl-L-2-pyrrolidine carboxamido) 1-thio-L-threo-α-D-
galacto-octopyranoside 2-(dihydrogen phosphate)[3] and the 
structure shown in fig. 1.  
Clotrimazole is an imidazole derivative with a broad spectrum of 
antimycotic activity. It is used for the local treatment of oropharyngeal 
candidiasis and vaginal yeast infections, and also used in fungal 
infections of the skin such as ringworm, athlete’s foot, and jock itch. 
Chemically Clotrimazole is 1-[(2-chlorophenyl) diphenylmethyl]-1H-
imidazole[4] and the structure shown in figure-2. 
 
 
Fig. 1: Structure of Clindamycin phosphate 
 
The literature survey reveals that the few HPLC methods are 
developed and validated for the estimation of Clindamycin and 
Clotrimazole combination with other drugs. The reported methods 
available for the estimation of Clindamycin individually are new 
validated bio-analytical high performance liquid chromatography 
method[5], spectrophotometric method[6], HPLC-UV[7,8], 
derivative spectrophotometric method[9], RP-HPLC[10-16], liquid 
chromatography/electro spray ionization mass spectrometry[17], 
capillary electrophoresis with an end-column electro 
chemiluminescence[18], gas liquid chromatography[19] and ultra 
high performance liquid chromatography-electro spray ionization 
tandem mass spectrometry [20]. 
 
 
Fig. 2: Structure of Clotrimazole 
 
Clotrimazole has been determined in different pharmaceutical 
preparations by stability-indicating high performance liquid 
chromatography method[21], high performance thin layer 
chromatography[22] and spcetrophotometric method[23,24], 
simultaneous estimation of Clotrimazole combination with other 
drugs[25-27]. Since there is no reported method on simultaneous 
estimation of Clindamycin and Clotrimazole in combined tablet dosage 
forms. The main objective of this study was to develop and validate the 
assay method of Clindamycin and Clotrimazole in tablet dosage forms. 
MATERIALS AND METHODS 
Materials 
All standard purified materials were used for this study. The 
solvents which are used in the preparation of solutions should be 
HPLC grade and obtained from Merck Specialties Private Limited, 
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Mumbai. Active pharmaceutical ingredients Clindamycin Phosphate and 
Clotrimazole were supplied by Spectrum Pharma Research Solutions, 
Hyderabad. The formulation was purchased in a local market. 
Instrumentation 
The High performance liquid chromatography system consists of 
water’s 2695 with 2996 module Photo Diode Array detectors 
equipped with a quaternary solvent delivery pump, automatic 
sample injector and column thermostat. The system was controlled 
by Empower 2 software and it is used for the analysis. 
Chromatographic conditions 
The chromatographic separation was performed on Hypersil BDS 
(250×4.6 mm,5 µm). The column temperature was maintained at 
300c. The mobile phase consisting of buffer and acetonitrile in the 
ratio of 48:52 with a flow rate of 1.0 ml/min. The detection 
wavelength was set at 220 nm and had given acceptable retention 
time and good resolution in between Clindamycin and Clotrimazole. 
The run time was taken as 10 min. 
Standard solution preparation 
Accurately weighed and transferred 10mg of Clindamycin and 20mg 
of Clotrimazole working standards into a 10 ml clean dry volumetric 
flask, add 7 ml of diluents, Sonicated for 5 minutes and make up to 
the final volume with diluents. 1 ml from the above two stock 
solutions was taken into a 10 ml volumetric flask and made up to 10 
ml. The standard solution consists of 100 µg/ml of Clindamycin and 
200µg/ml of Clotrimazole, respectively. 
Sample preparation 
25 tablets were weighed and calculate the average weight of each 
tablet than the weight equivalent to 25 tablets was transferred into a 
100 ml volumetric flask, 70 ml of diluent added and sonicated for 25 
min, further the volume made up with diluents and filtered. From 
the filtered solution 0.2 ml was pipette out into a 10 ml volumetric 
flask and made up to 10 ml with diluents. 
Preparation of buffer: 0.01N (KH2PO4) 
Accurately weighed 1.36 gm of Potassium dihydrogen Ortho 
phosphate in a 1000 ml of volumetric flask add about 900 ml of 
milli-Q water added and degas to sonicate and finally make up the 
volume with water and pH adjusted to 3 with dil. OPA. 
Method validation 
The optimized chromatographic method was validated according to 
the ICH guidelines for the validation of parameters like linearity, 
precision, accuracy, limit of detection (LOD), limit of quantification 
(LOQ) and robustness. Validation of different types of analytical 
procedures, as defined in the ICH Q2A guideline ‘Text on validation 
of analytical procedure. 
System suitability parameters 
System suitability parameters are validated by injecting five times of 
100µg/ml and 200µg/ml concentrations of standard solutions of 
Clindamycin phosphate and Clotrimazole in to the system. The 
parameters like resolution factor, theoretical plate and tailing factor 
were calculated.  
Linearity 
The range of linearity was evaluated by injecting the standard 
solution of Clindamycin and Clotrimazole in five different 
concentrations into the HPLC system. The linearity concentrations of 
Clindamycin and Clotrimazole were prepared in the ranges of 25-
150 µg/ml and 50-300 µg/ml. Plot a graph in between the peak area 
versus concentration (on X-axis and Y-axis). The linear regression 
coefficient, correlation coefficient was calculated. The correlation 
coefficient (r2
Repeatability of Clindamycin and Clotrimazole was validated by 
injecting the six times of standard solution and sample solutions in 
to the system. The areas of all the injections were taken and their 
corresponding values for mean, standard deviation and %RSD are 
calculated. 
Reproducibility 
Reproducibility of the method evaluated by injecting six times of 
100mg/ml, 200mg/ml concentrations of standard solutions and 
sample solution of Clindamycin and Clotrimazole on different days 
and different analysts or by different instruments. The areas of all 
injections were taken and their corresponding values for mean, 
standard deviation and % RSD of reproducibility are calculated. 
Accuracy 
The accuracy was validated by using a minimum of three different 
concentrations of standards, Clindamycin and Clotrimazole, 50%, 
100% and 150%. The percentage recoveries are analyzed of the 
obtained amount of Clindamycin and Clotrimazole in pharmaceutical 
formulations.  
Method robustness 
The robustness can be determined by varying the following 
parameters 
1) Flow rate: It can be determined by altering the flow rate from 1 
ml/min to 1.2 ml/min. The standard solution of Clindamycin and 
Clotrimazole was prepared and was injected by varying the flow rate 
along with the optimized method.  
2) Column temperature: It can be determined by varying the 
column temperature ±5%. The standard solution of Clindamycin and 
Clotrimazole was prepared and was injected by changing organic 
mobile phase composition along with the optimized method.  
3) Mobile phase: It can be determined by changing the organic 
mobile phase composition by ±10%. The standard solution of 
Clindamycin and Clotrimazole was prepared and was injected by 
changing an organic mobile phase composition along with the 
optimized method. 
LOD and LOQ 
Limit of detection (LOD) and limit of quantification (LOQ) of 
Clindamycin and Clotrimazole was calculated from the calibration 
curve method. The linearity solutions of Clindamycin and 
Clotrimazole were prepared and injected. LOD and LOQ were 
calculated by using following equations. LOD= (3.3σ/S), LOQ= 
(10σ/S). 
Where σ = standard deviation of the response; S =slope of the 
calibration curve of the analyze. 
RESULTS AND DISCUSSION 
Method development and optimization 
A simple RP-HPLC method for the simultaneous estimation of 
Clindamycin and Clotrimazole in pharmaceutical dosage forms. In 
method development the solubility of the active pharmaceutical 
ingredient was checked in different solvents like methanol and 
water. The Clindamycin was completely soluble in water and 
Clotrimazole is methanol soluble. Finally the standards are diluted 
by methanol and water in the ratio of 80:20.  
The different mobile phases like acetonitrile and potassium 
dihydrogen ortho phosphate buffer were used in different 
compositions with a flow rate of 1 ml/min but the peak resolution, 
retention time and tailing factor were not satisfactory. Finally by 
changing the composition ratio (48:52) of the mobile phase was 
selected at a flow rate of 1 ml/min.  
) should be 0.999. 
Precision 
Repeatability 
The chromatographic separation was tested by using different 
columns like Hybersil, ultima, kromosil (150×4.6 mm; 5 µm) 
columns maintained at different temperatures like 25,30,35 were 
used, but the retention time, peak resolution and tailing were not in 
the desired limits. Actual chromatographic separation was achieved 
on BDS Hybersil (250×4.6 mm; 5 µm) using mobile phase 
composition of (48:52) buffer and acetonitrile. 
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Table 1: System suitability parameters of standard solution 
S. No.  Clindamycin Clotrimazole 
  Rt Area USP Plate count USP tailing Rt Area USP Plate count USP tailing 
1  2.215 751380 2852 1.31 5.638 7168163 4470 1.26 
2  2.277 745868 3143 1.27 5.957 7228132 4859 1.25 
3  2.286 749940 3099 1.27 6.004 7233293 6242 1.24 
4  2.293 758163 3428 1.29 6.004 7233293 6242 1.24 
5  2.293 758163 3428 1.29 6.123 7248529 4875 1.22 
Mean   752702.8    7222282   
SD    5378.77    31202.8   
%RSD    0.71    0.43   
SD=Standard deviation; RSD= Relative Standard deviation; Rt= Retention Time 
 
System suitability parameters  
The system suitability tests were conducted before performing the 
validation and the parameters were within the acceptance criteria 
like retention times of Clindamycin and Clotrimazole were 2.2 
minutes and 5.7 minutes, respectively. The plate count was >2000, 
peak tailing was <2 and the %RSD of peak areas of standard were ≤ 
2.(Table 1), (fig. 3). Hence the proposed method was successfully 
applied to routine analysis without any problems. 
 
 
Fig. 3: HPLC chromatograph of standard solution (i. e. 
Clindamycin and Clotrimazole) 
 
Linearity 
The linearity of Clindamycin and Clotrimazole was prepared in the 
range of 25-150 µg/ml and 50-300µg/ml. These were represented 
by linear regression equation y (Clindamycin) =7319. x+2881 
(r2=0.999), y (Clotrimazole)=34358. x+13610 (r2
Clindamycin Clotrimazole 
=0.999). From the 
calibration curve the regression line for both drugs was linear. 
(Table 2), (fig. 4,5). 
 
Table 2: Linearity of Clindamycin and Clotrimazole 
Concentration 
(ppm) 
 Area Concentration 
(ppm)  
 Area 
 0  0  0  0 
 25  180013  50  1890194 
 50   374437  100  3699949 
 75  557979  150  5280411 
 100  744271  200  7108478 
 125  904671  250  8675551 
 150 1101466  300 10373947 
 
Precision 
Injected standard preparation six times in same concentration in to 
the system. The precision of analytical method expresses closeness 
of agreement between a series of measurements obtained from 
multiple sampling of the homogenous under the prescribed 
conditions. Reproducibility and Repeatability for Clindamycin and 




Fig. 4: Linearity graph of Clindamycin 
 
 
Fig. 5: Linearity graph of Clotrimazole 
 
Accuracy 
The percentage recoveries for Clindamycin and Clotrimazole were 
found to be 99-100% and the %RSD for Clindamycin and 
Clotrimazole were found to be 0.37 and 0.67. The results of recovery 
studies were shown in table 4. 
Robustness 
Robustness data for Clindamycin and Clotrimazole by changing the 
parameters like flow rate, temperature and mobile phase ratio. It 
was shown in table 5. 
 
Table 3: Determination of repeatability and intermediate precision for Clindamycin and Clotrimazole 
 
Drug 
 Repeatability Intermediate precision 
Peak area Std. Dev %RSD Peak area Std. Dev %RSD 
Clindamycin 753768 2130.09  0.28 750846 8073.8  1.1 
Clotrimazole 7246639 32443.1  0.44 7174052 75631.9  1.1 
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Table 4: Accuracy for standard solution 























 100  50  49.79  100.49  200  100  100.02  98.83 
 100  50  50.15  100.25  200  100  100.25  99.90 
 100  50  50.23  100.15  200  100  100.50  100.23 
 100  100  99.83  99.83  200  200  199.90  100.12 
 100  100  100.55  100.55  200  200  199.47  98.85 
 100  100  99.75  99.75  200  200  199.98  99.92 
 100  150  150.10  100.68  200  250  249.90  100.46 
 100  150  150.54  100.81  200  250  249.47  100.48 
 100  150  150.33  100.07  200  250  249.98  100.67 
 Mean    100.28     99.94 
 SD    0.371     0.673 
% RSD        0.37         0.67 
 
Table 5: Robustness: Flow rate 
Parameters Clilndamycin Clotrimazole 
Mean Area Std. Deviation %RSD Mean Area Std. Deviation %RSD 
Flow rate 1 ml/min 868401  19025.2  1.9 8499057  17994.8  1.8 
1.2 ml/mn 638079  9864.3  0.1 6322925  9967.9  0.2 
Temperature 250 285762 C  4211.0  1.5 6831608  174864.2  1.6 
350 703537 C  266104  1.8 6745830  194296.5  1.2 
Mobile phase -10% 645494  2780.3  0.4 6334026  5732.0  0.1 
+10% 861098  13188.1  1.5 8465523  125860.6  1.5 
 
Table 6: Limit of quantification and Limit of detection 
S. No. Parameters  Clindamycin Clotrimazole 
1  LOD  1.29  1.31 
2  LOQ  3.93  3.96 
 
Table 7: Assay of Clindamycin and Clotrimazole 
 Brand Name  Label Claim  Amount found  % Assay 
 CANDID-CL 
(glenmark) 
Clindamycin(100mg)  100.04± 0.28  100.04 
Clotrimazole(200mg)  200.26± 0.44  100.13 
 
Limit of detection (LOD) and limit of quantification (LOQ) 
The values of LOD and LOQ were calculated by using the slope and y-
intercept. The LOD and LOQ values for Clindamycin were found to be 
1.29 µg/ml and 3.93µg/ml and Clotrimazole were found to be 1.31 
µg/ml and 3.96µg/ml, respectively (Table 6). 
Assay 
The content of Clindamycin and Clotrimazole in the pharmaceutical 
dosage forms by using the developed method. The percentage purity 
of Clindamycin and Clotrimazole were found to be 100.04 % and 
100.13% and %RSD values for both Clindamycin and Clotrimazole 
were within limit of ≤2. (Table 7). 
CONCLUSION 
The proposed analytical technique of RP-HPLC is simple, accurate and 
precise method for the simultaneous estimation of Clindamycin and 
Clotrimazole in pharmaceutical dosage forms has been developed. The 
method was validated as per ICH guidelines. Statistical analysis proves 
that method is repeatable, sensitive for the analysis of Clindamycin and 
Clotrimazole in pharmceutical dosage forms.  
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